Cost-Effectiveness Analysis of Adding New Drug Thiozonide To Iv-Th Drug Regimens For Multidrug-Resistant Tuberculosis
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1496
https://www.valueinhealthjournal.com/article/S1098-3015(17)31830-2/fulltext
Title :
Cost-Effectiveness Analysis of Adding New Drug Thiozonide To Iv-Th Drug Regimens For Multidrug-Resistant Tuberculosis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31830-2&doi=10.1016/j.jval.2017.08.1496
First page :
A646
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1346